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Summary
Hemidesmosomes connect the extracellular matrix (ECM) to
intermediate filaments through ECM receptors and plakins
(plectin and BPAG1e). They affect tissue integrity, wound
healing, and carcinoma invasion [1]. Although biochemical
and time-lapse studies indicate that a6b4-integrin (ECM
receptor) and plectin play a central role in modulating hemi-
desmosome disassembly [2–5], the mechanisms controlling
hemidesmosome biogenesis in vivo remain poorly under-
stood. The nematodeC. elegans provides a powerful genetic
model to address this issue. We performed a genome-wide
RNA interference screen in C. elegans, searching for genes
that decrease the viability of a weak VAB-10A/plakin mutant.
We identified 14 genes that have human homologs with
predicted roles in different cellular processes. We further
characterized two genes encoding the chaperone CRT-1/cal-
reticulin and the HECT domain E3 ubiquitin ligase EEL-1/
HUWE1. CRT-1 controls by as little as 2-fold the abundance
of UNC-52/perlecan, an essential hemidesmosome ECM
ligand. Likewise, EEL-1 fine tunes by 2-fold the abundance
of myotactin, the putative hemidesmosome ECM receptor.
CRT-1 and EEL-1 activities, and by extension other genes
identified in our screen, are essential during embryonic
development to enable hemidesmosomes exposed to
mechanical tension to mature into a tension-resistant form.
Our findings should help understand how hemidesmosome
dynamics are regulated in vertebrate systems.
Results and Discussion
C. elegans Hemidesmosome-like Junctions Reorganize
during Embryonic Morphogenesis
C. elegans harbors junctions in areas where the epidermis
interacts with muscles and the cuticle, named fibrous organ-
elles, which have the hallmarks of vertebrate hemidesmo-
somes (Figures 1A and 1B; reviewed in [6]). These feature a
membrane plaque associated with intermediate filaments
and the plectin and BPAG1e homolog VAB-10A/plakin on
both apical and basal membranes [7]. Loss of VAB-10A or
intermediate filaments is characterized by a fragile epidermis
that splits internally, as observed in patients with defective
hemidesmosomes [7–9]. Fibrous organelles and vertebrate
hemidesmosomes differ through their membrane receptors.*Correspondence: lmichel@igbmc.fr
2These authors contributed equally to this work
3Present address: UMR CNRS 6023, 24 avenue des Landais, 63170 Aubie`re,
FranceInstead of a6b4-integrin, fibrous organelles contain either
LET-805/myotactin, with fibronectin type III repeats on their
basal side, or MUP-4 and MUA-3, with EGF repeats on their
apical side [10].
Fibrous organelles are essential for embryonic elongation,
a process during which the embryo transforms from an ovoid
into a vermiform larva [6, 11]. During this period, the organiza-
tion of fibrous organelles changes from puncta aligned along
the anterior-posterior axis (Figures 1Ca and 1Cb) to short
parallel circumferentially oriented stripes when the underlying
muscles start to contract (Figures 1Da and 1Db). Subse-
quently, fibrous organelles act as tendon-like structures that
transmit muscle tension to the cuticle [12, 13].
Identification of Fourteen Proteins Required
to Maintain a Functional Hemidesmosome
To define howC. elegans hemidesmosome maturation occurs,
we performed a genome-wide RNA interference (RNAi) screen
to find genes that are essential in animals with partially com-
promised VAB-10A/plakin. We chose the vab-10A(e698) allele
bearing a missense mutation in its long C-terminal domain [7].
Homozygous vab-10A(e698) animals have minor head
morphogenesis defects and fragile muscle attachments but
are fully viable [7, 14] (see Figures S2B and S2F available on-
line). In contrast, complete loss of vab-10A function leads to
embryonic lethality [7].
As described in Figure S1A, our screen ultimately identified
14 genes functionally interacting with vab-10A to generate
a normal hemidesmosome. We hereby refer to these as
enhancer of vab-10 (evab) genes (Figure 1E). Interestingly,
each evab gene has a close homolog in mammals (Figure 1E),
where they might also contribute to build hemidesmosomes.
Among EVAB proteins, two were previously known to be
required for fibrous organelle function. Specifically, VAB-19,
an ankyrin-repeat-containing protein related to the Kank
tumor suppressor, colocalizes with VAB-10A/plakin [8];
UNC-52, the nematode perlecan homolog, is the major extra-
cellular matrix (ECM) protein between muscles and the
epidermis [15]. Moreover, the RNA-binding protein MEC-8
controls unc-52 alternative splicing [16]. Their identification
validates our screening strategy.
We confirmed the aforementioned RNAi phenotypes with
loss-of-function mutations in vab-19, lst-3, eel-1, crt-1, hecd-
1, and egl-27 (Table S1). Besides vab-19, none of these genes,
which affect different cellular processes, had previously been
linked to hemidesmosome formation in any system. Each of
them, combined with vab-10A(e698), induced different
degrees of embryonic lethality (Emb) with poor elongation
and muscle detachment, as observed in vab-10A strong loss-
of-function embryos [7] (Figure 1E; Figures S2A–S2D) and/or
larvae with cuticle-muscle detachment causing paralysis and
strongly compromising development (Figures S2E–S2G0).
In the remainder of this work, we focus on two genes pre-
dicted to control protein turnover and/or stability. The first is
eel-1 [17], which encodes a homolog of the HECT E3 ubiquitin
ligase HUWE1. HUWE1 is involved in regulating the stability of
the tumor suppressor p53 and the activity of the oncoprotein
c-Myc [18]. The second is crt-1 [19], which encodes a homolog
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Figure 1. Structure and Maturation of C. elegans Hemidesmosomes
(A and B) Components and structure of mammalian hemidesmosomes (A) compared with C. elegans fibrous organelles (B). Proteins known or suspected
to interact are drawn adjacent. The following abbreviations are used: PM, plasma membrane; ECM, extracellular matrix.
(Ca–Db) Immunostaining of wild-type embryos at 1.7-fold (C) and 3-fold (D) stages with NE8/4C6 (muscle; red) and VAB-10A/plakin (green) antibodies.
VAB-10A pattern from boxed areas in (Ca) and (Da) is enlarged in (Cb) and (Db), respectively. Scale bar represents 10 mm.
(E) Identity, homology, and RNA interference (RNAi) phenotypes of evab genes. The following abbreviations are used: Emb, embryonic lethality; Lvl, larval
lethality with muscle detachment (see Figure S2G). Over 200 embryos after feeding RNAi (genes indicated with superscript 1) or 150 embryos after injection
of RNAi (all other genes) were observed. For screening strategy, see Figure S1; for double-mutant lethality, see Table S1.
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323of the chaperone protein CRT-1/calreticulin. For both EEL-1
and CRT-1, presumptive null mutants were available
(Figure 2A). Previous work had established that CRT-1/calreti-
culin is ubiquitously expressed [19]. Likewise, we found that an
eel-1::gfp transcriptional reporter is expressed in most cells
(Figure 2B).
Muscles Detach after the 2-Fold Stage in vab-10A
and evab Double Mutants
If evab genes really act with vab-10 in hemidesmosome
biogenesis, the prediction is that reducing evab function in
the vab-10A(e698) background should compromise fibrous
organelles, as observed in stronger vab-10 mutants. In vab-
10A(e698); crt-1(ok948) and vab-10A(e698); eel-1(ok1575)
double mutants, VAB-10A was normally expressed and
formed parallel stripes in areas where muscles were still
attached (Figures 2Fa–2Gc). However, in areas where muscles
detached from the outer border of the embryo, VAB-10A stain-
ing either failed to form stripes or was much reduced or absent
(Figures 2Fa–2Gc). This was not observed in evab or in vab-
10A(e698) single mutants (Figures 2C–2E). Staging vab-10A
(e698); crt-1(ok948) and vab-10A(e698); eel-1(ok1575) double
mutants revealed that VAB-10 distribution first became
abnormal at the 1.7-fold stage (Figures 2H–2J), which coin-
cides with the stage when muscles start to contract. Interest-
ingly, in vab-10A(e698); eel-1(ok1575) mutants, the striped
VAB-10A/plakin staining pattern generally remained normal
apically (arrow in Figure 2Gb) but disappeared basally (arrow-
head in Figure 2Gb). Thus, EEL-1 might act to remodel a
component present on the basal side.We conclude that evab genes help to strengthen the stability
of weakened hemidesmosomes. In vab-10A(e698) and evab
double mutants, hemidesmosomes initially form but cannot
maintain their integrity when exposed to muscle-induced
mechanical tension.
CRT-1 and EEL-1 Target UNC-52/Perlecan
and Its Receptor LET-805/Myotactin
To investigate the primary cause for fibrous organelle weak-
ening and define the potential targets of EEL-1 and CRT-1, we
tested whether eel-1 and crt-1 genetically interact with other
fibrous organelle components and examined whether they
affect their distribution. We found that reduction of eel-1 or
crt-1 function enhanced the phenotype of the conditional allele
vab-19(e1036cs), which is viable at 20C [8] (Figure 3A; Table
S2). Conversely, RNAi against vab-19 caused lethality in strong
eel-1orcrt-1mutants, which are viable at 20C (Figure 3A; Table
S2). These results suggest that genetic interactions observed
with vab-10A(e698) or vab-19(e1036cs) are unlikely to be allele
specific but instead reflect a general weakening of fibrous
organelles. Unexpectedly, we found that loss of eel-1 function
partially suppressed the embryonic lethality and paralysis
observed when unc-52 activity is compromised (gray boxes in
Figure 3A; Figure S3A–S3D). Together with the staining defect
shown in Figures 2Ga–2Gc, we might expect EEL-1 to antago-
nize the stability of a protein functionally interacting with UNC-
52. Interestingly, crt-1 specifically interacted with unc-52,
because the combined reduction of crt-1 and unc-52 functions
induced a highly penetrant embryonic lethality (Figure 3A),
suggesting that CRT-1 acts in the same pathway as UNC-52.
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Figure 2. Expression Patterns and Fibrous
Organelle Phenotypes of Selected evab Genes
(A) Conserved domains of EEL-1 and CRT-1. Hori-
zontal black bars indicate extent of deletion
alleles ok1575 and ok948; arrow indicates posi-
tion of GFP insertion. The following abbreviations
are used: DUF, domain of unknown function;
UBA, ubiquitin-associated domain; HECT, homol-
ogous to the E6-AP carboxyl terminus domain.
(B) A transcriptional eel-1::gfp construct is ex-
pressed at low levels in most cells.
(C–J) Immunostaining with NE8/4C6 (muscle;
red) and VAB-10A (green) antibodies of vab-10A
(e698) (C and H), crt-1(ok948) (D), eel-1(ok1575)
(E), vab-10A(e698); crt-1(ok948) (F and I), and
vab-10A(e698); eel-1(ok1575) embryos (G and J)
at 1.7-fold (H–J) or 3-fold (C–G) stages. Anti-
bodies from boxed areas in (Fa) and (Ga) are
enlarged in (Fb) and (Fc) and (Gb) and (Gc),
respectively. Arrows in (Fb) and (Gb) indicate
areas with detached muscles but normal VAB-
10A; arrowheads in (Fb) and (Gb) indicate areas
with abnormal VAB-10A; dotted lines in (Fc) and
(Gc) indicate expected muscle positions; arrow-
heads in (I) and (J) indicate areas with detached
muscles. Scale bar in (C) represents 10 mm.
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324Using specific antibodies, we found in eel-1(ok1575)
embryos that LET-805/myotactin level was approximately
50% increased compared to wild-type embryos, taking adhe-
rens junctions as internal controls (AJM-1; Figures 3B and 3C).
Intermediate filaments, VAB-10A, and perlecan levels were
unchanged (data not shown). This observation was confirmed
with western blot against LET-805 protein (Figures 3D and 3E).
Because EEL-1 is an E3 ubiquitin ligase, it might directly
target LET-805/myotactin for degradation or act indirectly.
Quantitative reverse transcriptase-polymerase chain reaction
(RT-PCR) analysis revealed that let-805 transcripts were 70%
more abundant in eel-1 mutants than in wild-type embryos
(tubulin transcript was used as an internal control;
Figure 3F). Because eel-1 almost equally increased let-805
mRNA and protein levels, we suggest that EEL-1 targets a
factor controlling let-805 expression. EEL-1 is unlikely to
mediate its effects through SKN-1, a known EEL-1 target
[17], or through CEP-1/p53, a potential target based on verte-
brate data [18] (Figure S3E). Thus, EEL-1 probably targets
another protein required for let-805 expression in the
epidermis.To confirm that the phenotype of the
vab-10A(e698); eel-1 double mutant
mainly results from elevated LET-805
levels, we increased LET-805 expres-
sion via a chromosome duplication con-
taining let-805 (sDp3). When combined
with vab-10A(e698), the duplication
sDp3 exhibited 14.3% muscle detach-
ment, in the same range as observed in
vab-10A(e698); eel-1 double mutants
(16%; Figure 3G; Figures S3F and S3G).
Consistent with the notion that LET-
805 is produced in the epidermis,
reducing eel-1 function specifically in
the epidermis through tissue-specific
RNAi [20] caused the same phenotype
as the eel-1(ok1575) mutation. Indeed,the percentage of embryos with detached muscles was similar
in both cases (19% versus 16%; Figure 3G; Figures S3H
and S3I).
Why does a 1.5- to 2-fold increase in the amount of LET-805/
myotactin become detrimental in the vab-10A(e698) back-
ground? A simple interpretation is that it strengthens
epidermis adhesion to the ECM and in turn slows down any
disassembly step necessary to allow fibrous organelles to
adopt a striped distribution. Consequently, they might rupture
if not remodeled in time during embryonic elongation. To test
this model, we reduced the elongation rate by affecting the
activity of C. elegans bH-spectrin (SMA-1), which is required
for fast elongation but not embryonic viability [21, 22]. We
found, as observed previously in vab-19; sma-1 double
mutants [14], that RNAi against sma-1 in vab-10(e698);
eel-1(ok1575) double mutants reduced both the number of
embryos with detached muscle and the overall area over
which muscles detached by half (Figures 3H–3J; Figure S3J).
We suggest that fine tuning LET-805 levels through EEL-1 is
crucial for correct fibrous organelle maturation in coordination
with embryonic elongation.
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Figure 3. EEL-1 Affects the Expression of the Fibrous Organelle Component LET-805
(A) Genetic interactions between selected evab genes. Viable evab mutants are shown in vertical columns; RNAi-targeted genes are shown in horizontal
rows. + and2 indicate fold increase or decrease, respectively, in lethality compared to the sum of lethality observed in single genes. The following symbols
are used: ++++, >10-fold increase; +++, 5- to 10-fold increase; ++, 2- to 5-fold increase; +,%2-fold increase; 0, no change;22,R2-fold decrease in lethality
or adult paralysis. See also Table S2 and Figures S3A–S3D. Asterisks indicate results confirmed by double mutants.
(Ba–Bd) Immunofluorescence images of wild-type (Ba and Bb), eel-1(ok1575) (Bc), and vab-10A(e698); eel-1(ok1575) (Bd) 2-fold embryos stained with
monoclonal antibodies against LET-805 (Bb–Bd, stars) and the junctional marker AJM-1 (Bb–Bd, arrows) with the same secondary antibody. (Bb) shows
a magnification of the region indicated in the dashed rectangle in (Ba); (Bc) and (Bd) show comparable areas in mutants.
(C) Morphometric quantification of stainings (n = 15).
(D and E) Western blot analysis (D) and densitometry quantification (E) of LET-805 protein in eel-1(ok1575) embryos relative to a-tubulin control.
(F) Quantitative RT-PCR of let-805mRNA in eel-1(ok1575) embryos relative to tba-1 control; vab-10A and unc-52 transcripts are unaffected by eel-1(ok1575).
(G) Percentage of embryos with detached muscles as visualized by VAB-10A/muscle immunostaining (Figures S3F–S3I). +/+;sDp3 indicates free
chromosome duplication sDp3; epi-RNAi indicates epidermis-specific eel-1(RNAi).
(H and I) Immunofluorescence images of untreated (H) or sma-1(RNAi)-fed (I) vab-10A(e698); eel-1(ok1575) embryos stained with VAB-10A antibodies and
a muscle marker (not shown). Dotted line indicates area with detached muscles; solid line indicates total embryo length.
(J) Ratio of body wall with detached muscles to total embryo length.
Scale bars in (Ba) and (H) represent 10 mm. *p < 0.05; **p < 0.01. Error bars indicate standard error of the mean.
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325The specific effect of EEL-1 on LET-805 expression could
explain why VAB-10A was locally more disorganized basally
in vab-10A(e698); eel-1(ok1575) double mutants (Figure 2Gb),
because LET-805/myotactin is present only basally [12]. It
can also account for the partial suppression of unc-52-deficient mutants by eel-1 (Figure 3A; Figures S3A–S3D),
because increasing LET-805/myotactin levels could lead
to improved adhesion when perlecan is reduced. Hence,
either too little of one component or too much of another
is harmful to hemidesmosomes. This suppression further
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Figure 4. CRT-1 Affects the Level of the Fibrous Organelle ECM Protein UNC-52/Perlecan
(Aa–Ad) Immunofluorescence images of wild-type (Aa and Ab), crt-1(ok948) (Ac), and vab-10A(e698); crt-1(ok948) (Ad) 2-fold embryos stained with
monoclonal antibodies against UNC-52 (Ab–Ad, stars), and AJM-1 (Ab–Ad, arrows) with the same secondary antibody. (Ab) shows a magnification of the
region indicated in the dashed rectangle in (Aa); (Ac) and (Ad) show comparable areas in mutants. Scale bar represents 10 mm.
(B) Morphometric quantification of stainings (n = 15).
(C and D) Western blot analysis (C) and densitometry quantification (D) of UNC-52 protein in crt-1(ok948) embryos at 15C relative to a-tubulin control.
(E) Quantitative RT-PCR of unc-52 transcripts in crt-1(ok948) embryos relative to tba-1 control.
(F) Percentage of embryos with detached muscles as visualized by VAB-10A immunostaining (Figure S4). lin-26p::CRT-1 indicates epidermis-specific CRT-1
expression; myo-3p::CRT-1 indicates muscle-specific CRT-1 expression. jDf2 homozygous embryos were identified by the absence of UNC-52 immunos-
taining and were ignored. Tissue-specific rescue experiments were performed at 20C; other experiments were performed at 15C.
*p < 0.05; **p < 0.01. Error bars indicate standard error of the mean.
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ally linked.
For crt-1, we observed that the signal for UNC-52/perlecan
was approximately 30% weaker in a crt-1 null mutant
compared to wild-type or vab-10A(e698) embryos, taking
AJM-1 as an internal control (Figures 4A and 4B). In contrast,
CRT-1 did not affect VAB-10A, intermediate filaments, and
LET-805/myotactin levels (data not shown). Western blot and
qPCR analysis confirmed that UNC-52 protein, but not
mRNA, levels were reduced (Figures 4C–4E). Calreticulin, the
human CRT-1 homolog, promotes protein folding in the endo-
plasmic reticulum [23]. The defects observed in crt-1 mutants
are thus consistent with CRT-1 promoting the folding of UNC-
52/perlecan, which is secreted by the epidermis [16]. In agree-
ment with this notion, rescuing CRT-1 function specifically in
the epidermis, but not in muscles, significantly rescued fibrous
organelle defects and muscle detachment (4.3% and 22%,
respectively, versus 17.2% in nontransgenic double mutants;
Figure 4F; Figures S4A–S4C).Because UNC-52/perlecan is the main ECM component
allowing muscles to attach to the epidermis [15], decreasing
the amount of secreted UNC-52 could easily account for the
muscle detachment observed in vab-10A(e698); crt-1(ok948)
double mutants. We confirmed this hypothesis by reducing
unc-52 copy number via a chromosome deletion containing
unc-52 (jDf2). When combined with vab-10A(e698), jDf2
heterozygosity induced marked increase in muscle detach-
ment (31%), which phenocopies the defects observed in
vab-10A(e698); crt-1 mutants (Figure 4F; Figures S4D and
S4E). The strong genetic interaction between crt-1 and
unc-52 (Figure 3A) is consistent with this result, because
strong unc-52 alleles are embryonic lethal [15]. Our observa-
tions are compatible with current knowledge of perlecan/
UNC-52 involvement in vertebrate skin biology, in that loss of
perlecan in mice affects wound healing [24].
A striking feature of our findings is that CRT-1 and EEL-1
target the main ECM component and its putative receptor in
C. elegans hemidesmosomes and modify their abundance
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327only by a factor of less than 2-fold. This difference, however
small, becomes quite detrimental in the background of a
slightly abnormal plakin mutant. Together, CRT-1 and EEL-1
activities contribute to the maturation of hemidesmosomes
into a mechanically resistant form. This indicates that hemi-
desmosome biogenesis is a precisely controlled event that
must be coordinated with epidermal cell shape changes
during elongation and that maintaining proper abundance of
hemidesmosome-related proteins is crucial for this process.
In conclusion, we have uncovered a set of evolutionarily
conserved genes that promote hemidesmosome maturation
into a structure that can withstand increased tension. Linking
these genes to hemidesmosome biogenesis would have
been difficult without a genetic approach, because many are
dispensable. We presume that vertebrate EVAB homologs
could also help reorganize hemidesmosomes under mechan-
ical or pathological stress conditions.
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